JCN Newswire - Recent Headline News
Yamaha Motor Co., Ltd. produced its 3 millionth automotive engine at its Iwata Main Factory, where these engines are assembled. The company's automobile engine business began in 1964 with joint development and production alongside Toyota Motor Corporation on their Toyota 2000GT (released 1967).
Teijin Frontier Co., Ltd., the Teijin Group's fiber-products converting company, announced that it has developed an advanced, high-comfort, high-density fabric, called DELTA 2000, that offers excellent performance for use in outerwear.
NTT has developed a phononic crystal (PnC) using micromachining technologies and demonstrated electrical control of traveling mechanical vibrations, or phonons. This result is the first demonstration of active control of phonons using external stimulation in MEMS-based PnCs.
Sysmex Corporation and Toppan Printing Co., Ltd. are to cooperate for the advancement in the genetic analysis testing industry, and to invest in RIKEN GENESIS Co., Ltd., a Toppan Printing subsidiary.
Toyo Engineering Corporation has been awarded a large-scale photovoltaic power plant project planned in Okayama Prefecture, Japan by Pacifico Energy K.K.
IHI Corporation received an order for two "IHI-SPB" LNG tanks to be installed in the Floating LNG Storage & Regasification Unit (FSRU) from Wison Group of Shanghai, China, who is known as the largest private EPC contractor in China.
Kuraray Noritake Dental Inc. has developed a highly durable zirconia that possesses both high strength and superior toughness. Kuraray is pursuing the marketing of this new and unique product in the dental material and other fields.
Toppan Printing Co., Ltd. has developed a version of its transparent high-barrier film, GL Film, that uses mechanically recycled PET film. It is expected to be used in products that require barrier packaging, such as food and pharmaceutical goods.
Yokogawa Electric Corporation has won an order from Hyundai Heavy Industries Co., Ltd. to supply control systems, safety instrumented systems, analysis systems, and other products for Stage-1 of the Jeddah South supercritical oil-fired thermal power plant project in Saudi Arabia.
Takara Bio Inc. has submitted an Investigational New Drug (IND) application to the Food and Drug Administration (FDA) dated April 30, 2014 in order to conduct a phase II clinical trial in the United States of the oncolytic virus HF10 in patients with unresected or metastatic malignant melanoma.